Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Azria

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Bulletin Du Cancer|January 3, 2006
[Targeted therapies and radiotherapy in colorectal cancer]David Azria, Nicolas Magné
Bulletin Du Cancer|April 24, 2007
[New tools in adjuvant breast cancer radiotherapy]Yazid Belkacémi, David Azria
Radiation Oncology (London, England)|January 16, 2010
Multidisciplinary approach of early breast cancer: the biology applied to radiation oncologyCéline Bourgier, Mahmut Ozsahin, David Azria
Bulletin Du Cancer|November 27, 2002
[Gemcitabine and pancreatic cancer]Patricia Prost, Marc Ychou, David Azria
Bulletin Du Cancer|January 13, 2004
[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients]Jean-Bernard Dubois, David Azria, Marc Ychou
Critical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony Gonçalves
Frontiers in Oncology|April 21, 2018
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the AcceleratorDavid Azria, Muriel Brengues, Sophie Gourgou, et al.
Bulletin Du Cancer|April 24, 2012
[Biologic modulation of ionizing radiation by Toll-like receptors agonists: towards an increase in the therapeutic index of radiotherapy?]Olivier Riou, David Azria, Christel Larbouret, et al.
Bulletin Du Cancer|November 1, 2006
[HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]Yazid Belkacémi, Joseph Gligorov, Louis Mauriac, et al.
Expert Review of Proteomics|February 19, 2013
Proteomic approaches to identify biomarkers predictive of radiotherapy outcomesJérôme Lacombe, David Azria, Alain Mange, et al.
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Bulletin Du Cancer|January 3, 2006
[Targeted therapies and radiotherapy in colorectal cancer]David Azria, Nicolas Magné
Bulletin Du Cancer|April 24, 2007
[New tools in adjuvant breast cancer radiotherapy]Yazid Belkacémi, David Azria
Radiation Oncology (London, England)|January 16, 2010
Multidisciplinary approach of early breast cancer: the biology applied to radiation oncologyCéline Bourgier, Mahmut Ozsahin, David Azria
Bulletin Du Cancer|November 27, 2002
[Gemcitabine and pancreatic cancer]Patricia Prost, Marc Ychou, David Azria
Bulletin Du Cancer|January 13, 2004
[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients]Jean-Bernard Dubois, David Azria, Marc Ychou
Critical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony Gonçalves
Frontiers in Oncology|April 21, 2018
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the AcceleratorDavid Azria, Muriel Brengues, Sophie Gourgou, et al.
Bulletin Du Cancer|April 24, 2012
[Biologic modulation of ionizing radiation by Toll-like receptors agonists: towards an increase in the therapeutic index of radiotherapy?]Olivier Riou, David Azria, Christel Larbouret, et al.
Bulletin Du Cancer|November 1, 2006
[HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]Yazid Belkacémi, Joseph Gligorov, Louis Mauriac, et al.
Expert Review of Proteomics|February 19, 2013
Proteomic approaches to identify biomarkers predictive of radiotherapy outcomesJérôme Lacombe, David Azria, Alain Mange, et al.
Pageof 25